Biotech3 hours ago
Abivax Shares Surge as New Trial Data Eases Safety Concerns Over Ulcerative Colitis Drug
Abivax shares surged nearly 36% after positive updated trial results for its ulcerative colitis drug obefazimod reassured investors following earlier safety concerns. New data showed strong...